+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Tinea Pedis Treatment Market by Treatment Category (Over The Counter, Prescription), Product Class (Allylamines, Azoles), Product Form, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Tinea Pedis Treatment Market by Treatment Category (Over The Counter, Prescription), Product Class (Allylamines, Azoles), Product Form, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Tinea Pedis Treatment Market by Treatment Category (Over The Counter, Prescription), Product Class (Allylamines, Azoles), Product Form, Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888825
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The tinea pedis treatment market is evolving rapidly, driven by changing patient needs, advancements in antifungal therapies, and shifting global healthcare dynamics. Senior decision-makers overseeing product portfolios, R&D, or strategic investments must navigate complex trends shaped by innovation, regulation, and regional demand for effective solutions.

Market Snapshot: Growth Trajectory and Leading Dynamics in Tinea Pedis Treatment

The tinea pedis treatment market grew from USD 1.57 billion in 2024 to USD 1.68 billion in 2025. It is expected to continue growing at a CAGR of 6.36%, reaching USD 2.28 billion by 2030. Forces such as the rise of antifungal innovations, increasing prevalence among aging populations, and advanced delivery systems are reshaping how both prescription and over-the-counter therapies are sourced and utilized. As healthcare accessibility improves and digital channels expand, new commercial models and product differentiation are emerging across diverse geographies.

Scope & Segmentation of the Tinea Pedis Treatment Market

This comprehensive report offers in-depth segmentation and coverage, enabling stakeholders to capitalize on opportunities across multiple axes:

  • Treatment Category: Over-the-counter remedies and prescription options, including oral and topical interventions for varying disease severities.
  • Product Class: Allylamines (butenafine, naftifine, terbinafine) and azoles (clotrimazole, econazole, miconazole), each developed to address diverse efficacy and safety profiles.
  • Product Form: Creams, gels, powders, and sprays tailored to improve dermal adherence, absorption, and application convenience.
  • Distribution Channel: Hospital pharmacies, online retail platforms, and community pharmacies serving both complex cases and broad-based consumer demand.
  • End User: Adults seeking rapid relief and pediatric populations requiring high safety standards and caregiver engagement.
  • Geographies Covered: Americas (including major U.S. states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (such as UK, Germany, France, Russia, Saudi Arabia, South Africa), and Asia-Pacific (China, India, Japan, Australia, Southeast Asia).
  • Company Analysis: Major players including Bayer Aktiengesellschaft, Johnson & Johnson, Novartis AG, GlaxoSmithKline plc, Pfizer Inc., Sanofi S.A., Bausch Health Companies, Teva Pharmaceutical Industries, Reckitt Benckiser, and Church & Dwight Co.

Key Takeaways for Strategic Decision-Makers

  • Therapeutic strategies are diversifying beyond traditional topical agents, with combination therapies and improved drug delivery systems gaining traction among clinicians managing resistant or recurrent infections.
  • Digital transformation is changing how patients access care; the expansion of telemedicine and online retail channels offers both convenience and new revenue streams for industry leaders.
  • Supply chain adaptability is increasingly vital, with manufacturers pursuing localized production, data-driven procurement, and partnerships to withstand regulatory shifts and fluctuating input costs.
  • Region-specific drivers such as reimbursement frameworks, cultural nuances, and patient education initiatives require tailored go-to-market approaches to ensure broad access and high adherence.
  • Competitive positioning hinges on the ability to leverage R&D investments, accelerate time-to-market for generics, and differentiate with advanced formulation technologies and targeted outreach programs.

Impact of 2025 United States Tariff Reforms on Supply Chain and Profitability

Recent U.S. tariff changes have affected the cost landscape for tinea pedis formulations by adjusting prices for imported active pharmaceutical ingredients and finished goods. Domestic manufacturers are expanding local production, while distribution partners are reevaluating pricing and product assortment strategies. Integrated procurement agreements and analytics-driven inventory management help companies maintain profitability and mitigate risk in an environment of ongoing regulatory and economic uncertainty.

Methodology & Data Sources

Report findings are based on primary interviews with clinical and supply chain leaders, coupled with extensive secondary research from journals, regulatory filings, and market databases. Quantitative models normalize data, and clustering algorithms refine segmentation, while real-world evidence and peer review safeguard accuracy and transparency throughout the analytical process.

Why This Report Matters

  • Senior executives can benchmark competitor strategies, identify innovation trends, and evaluate partnership opportunities using actionable insights.
  • Market segmentation enables precise targeting of promising product classes, patient cohorts, and regional growth hotspots.
  • Understanding supply chain risks and tariff impacts supports proactive operational planning and investment decisions, safeguarding business continuity.

Conclusion

The tinea pedis treatment market offers pathways for growth through innovation, digital engagement, and regional adaptation. Stakeholders equipped with robust analysis can enhance portfolio resilience and capitalize on transformation across the therapeutic landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising demand for natural and plant-based antifungal topical formulations due to consumer preference for clean-label ingredients
5.2. Growth of over-the-counter combination therapies combining antifungals with anti-inflammatory agents to improve patient compliance and outcomes
5.3. Advancements in topical drug delivery technologies like liposomal and nanoemulsion formulations enhancing antifungal skin penetration
5.4. Rapid expansion of telemedicine and digital dermatology platforms streamlining remote diagnosis and treatment of tinea pedis infections
5.5. Surge in generic antifungal drug launches post patent expirations driving competitive pricing and wider market accessibility
5.6. Increased adoption of prophylactic antifungal treatments among athletes and fitness enthusiasts to prevent outbreak in high-risk populations
5.7. Development of novel oral antifungal therapies featuring shorter treatment durations and improved hepatic safety profiles
5.8. Expansion of emerging markets in Asia Pacific and Latin America due to rising healthcare spending and growing awareness of fungal infections
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Tinea Pedis Treatment Market, by Treatment Category
8.1. Introduction
8.2. Over The Counter
8.3. Prescription
8.3.1. Oral
8.3.2. Topical
9. Tinea Pedis Treatment Market, by Product Class
9.1. Introduction
9.2. Allylamines
9.2.1. Butenafine
9.2.2. Naftifine
9.2.3. Terbinafine
9.3. Azoles
9.3.1. Clotrimazole
9.3.2. Econazole
9.3.3. Miconazole
10. Tinea Pedis Treatment Market, by Product Form
10.1. Introduction
10.2. Cream
10.3. Gel
10.4. Powder
10.5. Spray
11. Tinea Pedis Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital
11.3. Online Retail
11.4. Pharmacy
12. Tinea Pedis Treatment Market, by End User
12.1. Introduction
12.2. Adults
12.3. Pediatrics
13. Americas Tinea Pedis Treatment Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Tinea Pedis Treatment Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Tinea Pedis Treatment Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Bayer Aktiengesellschaft
16.3.2. Johnson & Johnson
16.3.3. Novartis AG
16.3.4. GlaxoSmithKline plc
16.3.5. Pfizer Inc.
16.3.6. Sanofi S.A.
16.3.7. Bausch Health Companies Inc.
16.3.8. Teva Pharmaceutical Industries Ltd
16.3.9. Reckitt Benckiser Group plc
16.3.10. Church & Dwight Co., Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. TINEA PEDIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. TINEA PEDIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. TINEA PEDIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. TINEA PEDIS TREATMENT MARKET: RESEARCHAI
FIGURE 26. TINEA PEDIS TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 27. TINEA PEDIS TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 28. TINEA PEDIS TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. TINEA PEDIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY BUTENAFINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY BUTENAFINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY NAFTIFINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY NAFTIFINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TERBINAFINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TERBINAFINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY CLOTRIMAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY CLOTRIMAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ECONAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ECONAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY MICONAZOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY MICONAZOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY GEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 103. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 104. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 105. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 106. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 107. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 108. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 109. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2018-2024 (USD MILLION)
TABLE 110. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2025-2030 (USD MILLION)
TABLE 111. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 112. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 113. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 114. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 115. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 120. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 121. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 122. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 123. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 124. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 125. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2018-2024 (USD MILLION)
TABLE 126. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2025-2030 (USD MILLION)
TABLE 127. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 128. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 129. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 130. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 131. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 134. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 202. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 203. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 204. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 205. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 206. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 207. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2018-2024 (USD MILLION)
TABLE 208. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2025-2030 (USD MILLION)
TABLE 209. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 210. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 211. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 212. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 213. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. GERMANY TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 218. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 219. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 220. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 221. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 222. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 223. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2018-2024 (USD MILLION)
TABLE 224. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2025-2030 (USD MILLION)
TABLE 225. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 226. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 227. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 228. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 229. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. FRANCE TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 250. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 251. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 252. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 253. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 254. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 255. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2018-2024 (USD MILLION)
TABLE 256. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2025-2030 (USD MILLION)
TABLE 257. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 258. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 259. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 260. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 261. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. ITALY TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 266. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 267. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 268. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 269. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 270. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 271. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2018-2024 (USD MILLION)
TABLE 272. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2025-2030 (USD MILLION)
TABLE 273. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 274. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 275. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 276. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 277. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. SPAIN TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. SOUTH AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2018-2024 (USD MILLION)
TABLE 330. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT CATEGORY, 2025-2030 (USD MILLION)
TABLE 331. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2018-2024 (USD MILLION)
TABLE 332. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, 2025-2030 (USD MILLION)
TABLE 333. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2018-2024 (USD MILLION)
TABLE 334. DENMARK TINEA PEDIS TREATMENT MARKET SIZE, BY PRODUCT CLASS, 2025-2030 (USD MILLION)
TABLE 335. DENMARK TINEA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Tinea Pedis Treatment market report include:
  • Bayer Aktiengesellschaft
  • Johnson & Johnson
  • Novartis AG
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Sanofi S.A.
  • Bausch Health Companies Inc.
  • Teva Pharmaceutical Industries Ltd
  • Reckitt Benckiser Group plc
  • Church & Dwight Co., Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.68 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.28 Billion
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Tinea Pedis Treatment Market Report 2025 - Product Image

Tinea Pedis Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Tinea Pedis (Athlete's Foot) Treatment - Global Strategic Business Report - Product Image

Tinea Pedis (Athlete's Foot) Treatment - Global Strategic Business Report

  • Report
  • 284 Pages
  • Global
From
Athlete's Foot (Tinea Pedis) - Pipeline Insight, 2025 - Product Image

Athlete's Foot (Tinea Pedis) - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Tinea Pedis - Pipeline Insight, 2025 - Product Image

Tinea Pedis - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Treatment of Skin Disease. Comprehensive Therapeutic Strategies. Edition No. 6 - Product Image

Treatment of Skin Disease. Comprehensive Therapeutic Strategies. Edition No. 6

  • Book

About the Tinea Pedis Drug Market

Tinea Pedis, commonly known as athlete's foot, is a fungal infection of the skin that affects the feet. It is caused by a variety of fungi, including Trichophyton, Epidermophyton, and Microsporum. Treatment for tinea pedis typically involves the use of antifungal drugs, such as terbinafine, itraconazole, and clotrimazole. These drugs are available in both topical and oral forms, and are used to treat the infection and prevent its recurrence. The tinea pedis drug market is a segment of the infectious diseases drugs market. It is composed of a variety of antifungal drugs used to treat tinea pedis. These drugs are available in both prescription and over-the-counter forms, and are used to treat the infection and prevent its recurrence. Some companies in the tinea pedis drug market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Bayer. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.